Firstly, we analyzed whether a different location of the primary tumor would affect the growth of a secondary tumor as location of a primary tumor was shown to have an impact on the prognosis of patients with metastatic disease (as shown in metastatic colorectal cancer patients with different Kras status receiving cetuximab) [46-48]. Here, KRAS is linked to neoplasm.